Agios Pharmaceuticals, Inc.

US$29.41As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:AGIOHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (4.74%)
Div yield —
ROE (32.95%)
Biotechnology
Beta (5Y) 0.62
PE TTM —
TSR TTM (31.98%)
Mkt cap US$1.759B
ROIC (102.84%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$34
14.30%
84.30%
Hold 3|0|5|2|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.34
0.37
0.39
0.38
24.08%
24.59%
23.40%
17.96%
Revenue$M
109.6
114.5
111.4
110.5
2.12%
5.33%
3.41%
1.72%
Peers (US$1.759B)
Cap (US$)
PE
1.779B
—
1.745B
—
Capital
TTM
5Y
10Y
Leveragex
1.109
0.081
0.061
EBIT/Intx
1.270
0.211
0.209
Own earn%
72.59
15.67
42.47
Sh yield%
29.17
42.93
44.28
Owners
Insiders/Inst%
5.98
75.51
Short interest%
2.66
SBC / revenue%
1.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
0–6
$1 testx
—
Incr. ROIC%
3